The graft versus host disease (GvHD) treatment market is anticipated to grow at a strong 8.2% (CAGR) during the coming years. By 2033, it is expected to have a sizable market size of US$ 5,960.7 million. As of 2023, the market is already valued at a significant US$ 2,713.6 million. Navigating the delicate interplay between …